Aspen Aerogels (NYSE:ASPN) Shares Up 8.2% - Should You Buy?

Key Points

• Aspen Aerogels shares rose 8.2% to about $6.76 in Monday’s trading, although volume was 94% below the stock’s average session volume.
• Analyst sentiment remains mixed: four analysts rate the stock a Buy, one a Hold and two a Sell, producing an overall “Hold” rating and a consensus price target of $5.69—below the recent share price.
• The company slightly beat quarterly earnings expectations, reporting a loss of $0.22 per share versus the expected $0.23 loss, while revenue of $49.85 million exceeded estimates; however, it continues to post negative profitability metrics and analysts expect a full-year loss.

Shares of Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) rose 8.2% during mid-day trading on Monday . The company traded as high as $6.68 and last traded at $6.7620. 92,454 shares were traded during mid-day trading, a decline of 94% from the average session volume of 1,595,835 shares. The stock had previously closed at $6.25.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. Barclays boosted their price target on Aspen Aerogels from $3.00 to $4.00 and gave the stock an "underweight" rating in a research report on Monday, May 11th. B. Riley Financial reaffirmed a "buy" rating on shares of Aspen Aerogels in a research report on Friday. Wall Street Zen raised shares of Aspen Aerogels from a "sell" rating to a "hold" rating in a research report on Saturday, May 16th. Roth Capital restated a "buy" rating and issued a $7.75 target price on shares of Aspen Aerogels in a research note on Friday. Finally, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Aspen Aerogels in a report on Wednesday, June 24th. Four investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $5.69.

Aspen Aerogels Stock Performance

The firm has a market cap of $529.19 million, a price-to-earnings ratio of -4.17 and a beta of 2.99. The company has a quick ratio of 2.54, a current ratio of 2.89 and a debt-to-equity ratio of 0.32. The company has a 50 day moving average of $5.51 and a 200 day moving average of $4.43.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The construction company reported ($0.22) earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. Aspen Aerogels had a negative return on equity of 29.30% and a negative net margin of 62.45%.The firm had revenue of $49.85 million during the quarter, compared to analyst estimates of $42.42 million. Aspen Aerogels has set its Q3 2026 guidance at -0.110--0.070 EPS. As a group, equities research analysts expect that Aspen Aerogels, Inc. will post -0.8 EPS for the current fiscal year.

Institutional Trading of Aspen Aerogels

Institutional investors have recently added to or reduced their stakes in the stock. Acadian Asset Management LLC acquired a new position in Aspen Aerogels during the 1st quarter worth $43,000. Tower Research Capital LLC TRC raised its stake in shares of Aspen Aerogels by 184.6% in the 2nd quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company's stock valued at $43,000 after purchasing an additional 4,693 shares in the last quarter. Royal Bank of Canada lifted its position in shares of Aspen Aerogels by 95.8% during the first quarter. Royal Bank of Canada now owns 8,523 shares of the construction company's stock worth $29,000 after purchasing an additional 4,169 shares during the last quarter. Prelude Capital Management LLC bought a new position in shares of Aspen Aerogels during the third quarter worth about $70,000. Finally, Occudo Quantitative Strategies LP bought a new position in shares of Aspen Aerogels during the third quarter worth about $72,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company's product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source